Metrix BioMed brings innovative diagnosis to market. MBI is a point of care diagnostics company specializing in CLIA waived testing. Metrix BioMed engages physicians via its direct sales in certain markets and is represented by distribution channels in others. Metrix Labs, an MBI subsidiary, provides Drugs of Abuse confirmation testing via EIA, GC/MS, LC/MS, and LC/MS/MS devices.
For more information on Metrix BioMed, visit www.metrixbiomed.com
For more information on Metrix Labs, visit www.metrixlabs.com
Follow us on twitter @metrixbiomed for the most up-to-information on CLIA waived testing, job postings, and industry relevant studies and data.
Company’s Keywords:
clia waived tests, point of care testing, in vitro diagnostics, toxicology lab
<3
<
<2010